Multi-gene assays: effect on chemotherapy use, toxicity and cost in estrogen receptor-positive early stage breast cancer.
CONCLUSION: MGAs differ in chemotherapy use and related outcomes for women with estrogen receptor-positive early breast cancer.
PMID: 30663337 [PubMed - as supplied by publisher]
Source: Journal of Comparative Effectiveness Research - Category: General Medicine Tags: J Comp Eff Res Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Databases & Libraries | General Medicine | Genetics | Study | Toxicology | Women